Statistics
Publications
3
Citations
272
H-Index
3
Active since
2011
Affiliations
Emeline Evrot is an author at Novartis (Switzerland) specializing in jak2 mutations, pharmacology, and jak inhibitors.
Publications per year
2011–2013
3
3
Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition
Oliver Weigert, Andrew A. Lane, Liat Bird et al. · The Journal of Experimental Medicine · 2012 · 162 citations · Full text
Medicine, Oncology, Pharmacology +14
Fabienne Baffert, Emeline Evrot, Nicolas Ebel et al. · Blood · 2011 · 28 citations
1–3 of 3